Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy

NCT02644486 is registered in ClinicalTrials.gov with Zhi-Hong Liu, M.D. as lead sponsor.

NCT NCT02644486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02644486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
Lead sponsor
Zhi-Hong Liu, M.D.
Phase
Not applicable
Overall status
Terminated
Start date
January 31, 2016
Completion date
February 28, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and glomerulopathy